Patents by Inventor Barbara Schaeffler

Barbara Schaeffler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of headache using anti-CGRP antibodies hereof
    Patent number: 12630614
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof. This invention pertains to methods of treatment of headache disorders, such as migraine, using antibodies and fragments thereof (including Fab fragments) that specifically bind to human Calcitonin Gene Related Peptide (hereinafter “CGRP”).
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: May 19, 2026
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20250368726
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 9, 2025
    Publication date: December 4, 2025
    Inventors: Roger K. CADY, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20250368727
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 9, 2025
    Publication date: December 4, 2025
    Inventors: Roger K. CADY, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Acute treatment and rapid treatment of headache using anti-CGRP antibodies
    Patent number: 12391749
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: February 23, 2023
    Date of Patent: August 19, 2025
    Assignee: H. Lundbeck A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Treatment of headache using anti-CGRP antibodies
    Patent number: 12384836
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: February 23, 2023
    Date of Patent: August 12, 2025
    Assignee: H. Lundbeck A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Treatment of headache using anti-CGRP antibodies
    Patent number: 12215145
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: March 19, 2024
    Date of Patent: February 4, 2025
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Acute treatment and rapid treatment of headache using anti-CGRP antibodies
    Patent number: 12215144
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: March 19, 2024
    Date of Patent: February 4, 2025
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES
    Publication number: 20240343784
    Abstract: Methods for treatment or prevention of medication overuse headache are provided. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: November 16, 2023
    Publication date: October 17, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240270832
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 15, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240239880
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: March 19, 2024
    Publication date: July 18, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240076359
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 23, 2023
    Publication date: March 7, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240067708
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 23, 2023
    Publication date: February 29, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Treatment of headache using anti-CGRP antibodies
    Patent number: 11639381
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: May 2, 2023
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Acute treatment and rapid treatment of headache using anti-CGRP antibodies
    Patent number: 11639380
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: January 8, 2020
    Date of Patent: May 2, 2023
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF
    Publication number: 20220251178
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof. This invention pertains to methods of treatment of headache disorders, such as migraine, using antibodies and fragments thereof (including Fab fragments) that specifically bind to human Calcitonin Gene Related Peptide (hereinafter “CGRP”).
    Type: Application
    Filed: February 18, 2020
    Publication date: August 11, 2022
    Inventors: Roger K. CADY, Jeffrey T.L. SMITH, Joseph HIRMAN, Barbara SCHAEFFLER, Lahar MEHTA
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20200299368
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 18, 2020
    Publication date: September 24, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20200216524
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 9, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler
  • TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES
    Publication number: 20200216525
    Abstract: Methods for treatment or prevention of medication overuse headache are provided. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 9, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler
  • METHODS AND UNIT DOSE FORMULATIONS FOR THE INHALATION ADMINISTRATION OF AMINOGLYCOSIDE ANTIBIOTICS
    Publication number: 20080095717
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: October 24, 2007
    Publication date: April 24, 2008
    Applicant: CHIRON CORPORATION
    Inventors: Robert Speirs, Barbara Schaeffler, Peter Challoner
  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Publication number: 20050207987
    Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.
    Type: Application
    Filed: May 10, 2005
    Publication date: September 22, 2005
    Applicant: Chiron Corporation
    Inventors: Robert Speirs, Barbara Schaeffler, Peter Challoner